Session Chair Profile
Ph.D., CEO, Insilico Medicine, Inc
Biography
Alexander is the Chief Scientific Officer of the Biogerontology Research Foundation, a UK-based registered charity supporting ageing research worldwide. He is also the director of the International Aging Research Portfolio knowledge management project, chief scientist of Youth Laboratories and the adjunct professor of the Moscow Institute of Physics and Technology. He holds two Bachelor Degrees from Queen’ s University, a Masters in Biotechnology from Johns Hopkins University, and a PhD in Biophysics from the Moscow State University. Alex Zhavoronkov is the author of over 90 research publications in the peer-reviewed journals and books including “The Ageless Generation: How advances in biomedicine will transform the global economy” (Palgrave Macmillan, 2013) and “Dating AI: A Guide to Falling in Love with Artificial Intelligence” (RE/Search, 2012).
Session Abstract – PMWC 2018 Silicon Valley
Session Synopsis: AI has the potential to expedite the clinical drug discovery and development process by applying sophisticated algorithms to the analysis and mining of different data sources to predict molecule behavior and suitability as drug targets or therapeutic entities. This session will cover different approaches and AI platforms, and how they will impact the pharmaceutical industry and specifically, the drug discovery and development processes.
